USPTO serial 77231567
AOBO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- VOHRA, SANJEEV KUMAR
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AOBO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David W. Grace
DAVID W. GRACE LOEB & LOEB LLP10100 SANTA MONICA BLVD STE 2200LOS ANGELES, CA 90067-4120UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in chemotherapy, herbal supplements for the treatment of the digestive system, respiratory system, immune system, circulatory system, reproductive system, nervous system, namely, antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceutical; bismuth preparations for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; anticoagulants; antidepressants; appetite suppressants; pharmaceuticals for the treatment of gout, heart rhythm disorders, allergic rhinitis and asthma, diabetes, gastro-intestinal diseases and hormonal disorders; pharmaceuticals for inhalation for the treatment of pulmonary hypertension; pharmaceuticals for ocular or intraocular surgery; pharmaceuticals for the prevention of osteoporosis; pharmaceuticals for use in dermatology; pharmaceuticals for wounds; pharmaceuticals for use in urology; pharmaceuticals against dry skin caused by pregnancy, chloasma, for hydrating the skin during pregnancy, for pregnancy blemishes, for preventing blemishes during pregnancy; potassium preparations; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; dietary supplement drink mixes; raw medicines, namely, ointments for medical use or medicinal oils, anti-rheumatic oil, coryza oil, essential embrocation; gynecological products, namely, vaginal washes, medicinally treated sanitary towels; medicines used to support the health of the circulatory and female reproductive system, namely, medicines for the treatment of menorrhagia or continuous uterine bleeding, medicines for activating blood circulation, medicines for regulating menstruation, medicines for the treatment of endometritis and pelvic inflammatory disease; traditional Chinese medicines, namely, ointments for medical use or medicinal oils, anti-rheumatic oil, coryza oil, essential embrocation, medicinal teas, ginseng for medicinal use, herbal medicine, for the treatment of the digestive system, respiratory system, immune system, circulatory system, female reproductive system and nervous system; medicated balms; medicinal teas, ginseng for medicinal use; herbal medicine, for the treatment of the digestive system, respiratory system, immune system, circulatory system, female reproductive system, nervous system; herbal medicines; medicinal sweets; dietary supplements; food supplements, herbal supplements, homeopathic supplements, meal replacement and dietary supplement drink mixes, nutraceuticals for use as a dietary supplement; nutritional additives for medical purposes for use in foods for human consumption; nutritional supplements; powdered nutritional supplement drink mix; dietary supplemental drinks; vitamin and mineral supplements; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; vitamin supplements; soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of gynecological disorders; medicinal herbs in dried or preserved form; pharmaceutical preparations for the treatment of colds and fevers; pharmaceutical preparations for the treatment of enuresis; herb teas for medicinal purposes | ACTIVE | — |
| 029 | Soy protein for use as a food additive; condiments, namely, pepper oil; soybean oil, soybean milk; dried edible algae as a non-medical supplement; milk beverages with high milk content | ACTIVE | — |
| 030 | coffee; herbal coffee substitutes; beverages containing coffee; coffee with additives; tea; sugar free and sugarless sweets; flavoring additives for non-nutritional purposes; cakes; ice cream; condiments, namely, pepper sauce; soybean molasses; cocoa beverages with milk; vinegar; flavor enhancers used in food and beverage products; processed herbs; prepared coffee and coffee-based beverages | ACTIVE | — |
| 032 | Beer containing soy peptide; fruit juice; drinking water and mineral spring water; cola drinks; soy-based beverages not being milk substitutes; powders used in the preparation of soft drinks; energy drinks; soft drinks; non-alcoholic beer; beer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by American Oriental Bioengineering, Inc.
- Other trademarks owned by American Oriental Bioengineering, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 032
- Similar marks named AOBO
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 5, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 3, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 19, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 6, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 5, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 24, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 24, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jun 24, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2008 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Apr 22, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2007 | NWAP | NEW APPLICATION ENTERED | — |